Holy Cross Health is a clinical research site located in Fort Lauderdale, Florida, United States 33308.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Holy Cross Health has participated in 7 clinical trials with 3 currently active.
Therapeutic areas: Amyotrophic Lateral Sclerosis, Parkinson Disease, Cancer.
Sponsors: Amylyx Pharmaceuticals Inc., Alexza Pharmaceuticals, Inc., EMD Serono Research & Development Institute, Inc..
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Holy Cross Health has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Holy Cross Health has 7 clinical trials on record, with 3 currently active. Their work covers Amyotrophic Lateral Sclerosis, Parkinson Disease, Cancer.
Yes — Holy Cross Health holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.